Course description
Biomarkers in Neurodegenerative Diseases
Biomarkers are increasingly required for effective research into neurodegenerative diseases. They are critical for diagnosis, disease monitoring and will be key for measuring target engagement of disease modifying therapies.
PhD students working in the field of neurodegeneration require a working knowledge of a range of biomarkers to correctly interpret scientific literature and to design and conduct successful and ambitious research studies.
University College London and University of Gothenburg are leading international centres with complementary expertise in fluid and imaging biomarkers. This collaboration would be expected to strengthen the quality of biomarker training across both institutions and beyond, as well as fostering new research collaborations and providing delegates with outstanding networking opportunities.
Do you work at this organisation and want to update this page?
Is there out-of-date information about your organisation or courses published here? Fill out this form to get in touch with us.
Upcoming start dates
Training Course Content
The aims will be to provide basic and practical knowledge of fluid and brain imaging-based biomarkers for neurodegenerative diseases. Participants will be expected to achieve a broad understanding of the following advanced brain imaging and neurochemistry technologies used as research and clinical tools in neurodegenerative diseases:
Neurochemistry (liquid-based biomarkers):
- Biomarkers in cerebrospinal fluid
- Biomarkers in blood
- Structural and functional magnetic resonance imaging (MRI)
- Positron emission tomography (PET)
- Single-photon emission computed tomography (SPECT)
- Digital biomarkers
Expenses
Please visit the University website for more information about tuition fees